Immuno-Biological Laboratories Co Ltd
TSE:4570
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Immuno-Biological Laboratories Co Ltd
Immuno-Biological Laboratories Co Ltd
Capital Expenditures
Immuno-Biological Laboratories Co Ltd
Capital Expenditures Peer Comparison
2309
2370
4880
2183
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Immuno-Biological Laboratories Co Ltd
TSE:4570
|
Capital Expenditures
-¥18.7m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
11%
|
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Capital Expenditures
-¥6.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-6%
|
|
S
|
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
|
Capital Expenditures
-¥8.6B
|
CAGR 3-Years
-97%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
-17%
|
|
|
Medinet Co Ltd
TSE:2370
|
Capital Expenditures
-¥77.1m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
12%
|
CAGR 10-Years
5%
|
|
|
CellSource Co Ltd
TSE:4880
|
Capital Expenditures
-¥359m
|
CAGR 3-Years
-122%
|
CAGR 5-Years
-71%
|
CAGR 10-Years
N/A
|
|
|
Linical Co Ltd
TSE:2183
|
Capital Expenditures
-¥6.5m
|
CAGR 3-Years
54%
|
CAGR 5-Years
37%
|
CAGR 10-Years
5%
|
See Also
What is Immuno-Biological Laboratories Co Ltd's Capital Expenditures?
Capital Expenditures
-18.7m
JPY
Based on the financial report for Mar 31, 2024, Immuno-Biological Laboratories Co Ltd's Capital Expenditures amounts to -18.7m JPY.
What is Immuno-Biological Laboratories Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
11%
The average annual Capital Expenditures growth rates for Immuno-Biological Laboratories Co Ltd have been -12% over the past three years , and 11% over the past ten years .
You don't have any saved screeners yet
